Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)

产品名称	Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)
目录号	NBR-0472
别名	CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0472-100UG	100ug	￥550	请咨询
NBR-0472-1MG	1mg	￥3500	请咨询
NBR-0472-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human DC-SIGN / CD209 Antibody (INSERM patent anti-DC-SIGN, Research Use)
产品编号：NBR-0472
针对靶点：DC-SIGN / CD209
抗体药商品名：INSERM patent anti-DC-SIGN
抗体药描述：The drug is a recombinant fully human anti-DC-SIGN monoclonal antibody, being developed by INSERM.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: CD209
Synonyms: CDSIGN; CLEC4L; DC-SIGN; DC-SIGN1
Target Description: Pathogen-recognition receptor expressed on the surface of immature dendritic cells (DCs) and involved in initiation of primary immune response. Thought to mediate the endocytosis of pathogens which are subsequently degraded in lysosomal compartments.
Ensembl: ENSG00000090659
Uniprot: Q9NNX6